Re: Kyung et al.: Changes in Weight and Metabolic Syndrome Are Associated With Prostate Growth Rate Over a 5-Year Period (Urology 2017;103;185-190).
作者信息
Ashrafi-Asgarabad Ahad, Ayubi Erfan, Safiri Saeid
机构信息
Department of Epidemiology, Bam University of Medical Sciences, Bam, Iran.
Department of Epidemiology, School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
出版信息
Urology. 2017 May;103:274-275. doi: 10.1016/j.urology.2016.10.052. Epub 2016 Dec 27.
Abstract
摘要
相似文献
1
Re: Kyung et al.: Changes in Weight and Metabolic Syndrome Are Associated With Prostate Growth Rate Over a 5-Year Period (Urology 2017;103;185-190).回复：Kyung等人：体重和代谢综合征的变化与5年期间前列腺生长速率相关（《泌尿学》2017年；第103卷；第185 - 190页）
Urology. 2017 May;103:274-275. doi: 10.1016/j.urology.2016.10.052. Epub 2016 Dec 27.
2
Re: Changes in Weight and Metabolic Syndrome are Associated with Prostate Growth Rate over a 5-Year Period.回复：体重和代谢综合征的变化与5年期间前列腺生长速率相关。
J Urol. 2017 Dec;198(6):1184-1185. doi: 10.1016/j.juro.2017.09.048. Epub 2017 Sep 19.
3
Re: Fascelli et al: Combined Biparametric Prostate Magnetic Resonance Imaging and Prostate-specific Antigen in the Detection of Prostate Cancer: A Validation Study in a Biopsy-naive Patient Population (Urology 2016;88:125-134).回复：法塞利等人：双参数前列腺磁共振成像与前列腺特异性抗原联合检测前列腺癌：在未经活检患者群体中的验证研究（《泌尿外科》2016年；88卷：125 - 134页）
Urology. 2016 Sep;95:223. doi: 10.1016/j.urology.2016.04.011. Epub 2016 Apr 22.
4
Re: Kryvenko et al.: Prostate-specific Antigen Mass Density - A Measure Predicting Prostate Cancer Volume and Accounting for Overweight and Obesity-related Prostate-specific Antigen Hemodilution (Urology, 2016;90:141-147).关于：克里文科等人：前列腺特异性抗原质量密度——一种预测前列腺癌体积并考虑超重和肥胖相关前列腺特异性抗原稀释的指标（《泌尿外科》，2016年；90卷：141 - 147页）
Urology. 2016 Apr;90:228-9. doi: 10.1016/j.urology.2016.01.013. Epub 2016 Jan 22.
5
Re: Al-Azab R, Toi A, Lockwood G, et al. Prostate volume is strongest predictor of cancer diagnosis at transrectal ultrasound-guided prostate biopsy with prostate-specific antigen values between 2.0 and 9.0 ng/mL (Urology 69:103-107, 2007).回复：Al-Azab R、Toi A、Lockwood G等人。在经直肠超声引导下前列腺活检时，对于前列腺特异性抗原值在2.0至9.0 ng/mL之间的情况，前列腺体积是癌症诊断的最强预测指标（《泌尿外科》第69卷：103 - 107页，2007年）。
Urology. 2008 Oct;72(4):951. doi: 10.1016/j.urology.2007.07.079.
6
Re: Billis et al.: Does the type of prostatic atrophy influence the association of extent of atrophy in needle biopsies and serum prostate-specific antigen levels? (Urology 2009;74:1111-1115).
Urology. 2010 May;75(5):1239; author reply 1240. doi: 10.1016/j.urology.2009.12.053.
7
Re: Deebel et al.: Prostate Cancer in Transgender Women: Incidence, Etiopathogenesis, and Management Challenges (Urology 2017;110:166-171).回复：迪布尔等人：《跨性别女性中的前列腺癌：发病率、病因发病机制及管理挑战》（《泌尿外科杂志》2017年；第110卷：第166 - 171页）
Urology. 2018 Jan;111:240. doi: 10.1016/j.urology.2017.09.031. Epub 2017 Oct 16.
8
Re: Trends in Prostate-Specific Antigen Screening, Prostate Biopsies, Urology Visits, and Prostate Cancer Treatments from 2000 to 2012.关于：2000年至2012年前列腺特异性抗原筛查、前列腺活检、泌尿外科就诊及前列腺癌治疗的趋势
J Urol. 2016 May;195(5):1473-1474. doi: 10.1016/j.juro.2016.02.052. Epub 2016 Feb 15.
9
Re: De Castro et al.: Effect of flexible cystoscopy on serum prostate-specific antigen values. (Urology 2009;73:237-240).回复：德卡斯特罗等人：软性膀胱镜检查对血清前列腺特异性抗原值的影响。（《泌尿外科》2009年；73卷：237 - 240页）
Urology. 2009 Jun;73(6):1428. doi: 10.1016/j.urology.2008.09.004.
10
Re: Kim et al.: detection rates of nonpalpable prostate cancer in Korean men with prostate-specific antigen levels between 2.5 and 4.0 ng/ml (Urology 2010;76:919-922).
Urology. 2011 Apr;77(4):1013-4; author reply 1014. doi: 10.1016/j.urology.2010.11.051.
引用本文的文献
1
Letter to the editor: Phosphorus as predictive factor for erectile dysfunction in middle aged men: A cross sectional study in Korea; Methodological issues to avoid prediction fallacy.致编辑的信：磷作为中年男性勃起功能障碍的预测因素：韩国的一项横断面研究；避免预测谬误的方法学问题。
Investig Clin Urol. 2017 Mar;58(2):146-147. doi: 10.4111/icu.2017.58.2.146. Epub 2017 Feb 7.
Zotero 插件